US Stock MarketDetailed Quotes
KNSA Kiniksa Pharmaceuticals International
- 22.340
- +0.300+1.36%
Trading Nov 27 15:55 ET
1.61BMarket Cap-186166P/E (TTM)
22.480High21.935Low116.81KVolume22.100Open22.040Pre Close2.60MTurnover0.69%Turnover Ratio111.70P/E (Static)72.20MShares28.15052wk High3.69P/B376.63MFloat Cap16.47052wk Low--Dividend TTM16.86MShs Float32.880Historical High--Div YieldTTM2.47%Amplitude5.010Historical Low22.252Avg Price1Lot Size
About Kiniksa Pharmaceuticals International Company
Kiniksa Pharmaceuticals International Plc is a commercial-stage biopharmaceutical company. It engages in discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases with significant unmet medical need. The company was founded on April 9, 2024 and is headquartered in London, United Kingdom.
Company Profile
SymbolKNSA
Company NameKiniksa Pharmaceuticals International
Listing DateMay 24, 2018
Issue Price18.00
Founded2024
CEOMr. Sanj K. Patel
MarketNASDAQ
Employees297
Fiscal Year Ends12-31
Address23 Old Bond Street,3rd Floor
CityLondon
ProvinceGreater London
CountryUnited Kingdom of Great Britain and Northern Ireland (the)
Zip CodeW1S 4PZ
Phone44-781-431-9100
Websitehttps://www.kiniksa.com
Company Executives
- Name
- Position
- Salary
- Sanj K. Patel
- Chief Executive Officer and Chairman of the Board
- 5.30M
- Ross Moat
- Senior Vice President and Chief Commercial Officer
- --
- Michael R. Megna
- Chief Accounting Officer and Group Vice President, Finance
- --
- John F. Paolini, M.D.,PhD
- Senior Vice President and Chief Medical Officer
- 1.79M
- Mark Ragosa
- Senior Vice President and Chief Financial Officer
- --
- Eben Tessari
- Senior Vice President and Chief Operating Officer
- 1.75M
- Cantey Boyd
- Director
- --
- Dr. Stephen R. Biggar,M.D.,PhD
- Independent Director
- 371.96K
- Tracey L. McCain, Esq.
- Independent Director
- 365.36K
- Kimberly J. Popovits
- Independent Director
- 362.66K
- Thomas R. Malley
- Independent Director
- 380.36K
- G. Bradley Cole
- Independent Director
- 365.36K
- Dr. Richard S. Levy,M.D.
- Independent Director
- 459.75K
- Dr. Felix J. Baker,PhD
- Lead Independent Director
- 411.06K
- Dr. Barry D. Quart,Pharm.D.
- Independent Director
- 372.55K
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data